At $187.25 and trading at 29.2x Trailing P/E and 13.7x EV/EBITDA, XOM reflects full upstream pricing power while capital productivity compresses, evidenced by ROIC decaying from 29.8% in FY 2022 to 9.9% TTM and 7.5% in Q1 2026. Free cash flow yield sits at an unappealing 2.54% against $47.66B of total debt, creating an asymmetrical risk profile that demands pairing long exposure against structural refining and upstream laggards rather than outright directional beta.
XOM exhibits a 0.60 Pearson r correlation to WTI crude with a 0.38% weekly return elasticity per 1.0% crude move, supported by balance sheet solvency metrics including an Altman Z-score of 4.62 and net debt contained by a 0.19x Debt-to-Equity ratio.
PEARSON R DCOILWTICO: +0.60 | ALTMAN Z: 4.62 | D/E: 0.19xDespite quarterly cash flow volatility, the business maintained $2.23B of quarterly FCF in Q1 2026 and generated $23.61B FCF in FY 2025, backstopping its 2.20% cash dividend yield alongside an options skew reflecting a 0.41 Put/Call ratio.
DIVIDEND YIELD: 2.20% | FY25 FCF: $23.61B | PUT/CALL RATIO: 0.41Consensus maintains a mean target of $216.29 representing 15.5% upside, anchored by institutional long-term cost integration across key suppliers like SLB (34% exposure) and BKR (24% exposure) in deepwater and unconventional assets.
MEAN PT: $216.29 | CONSENSUS UPSIDE: 15.5% | FORWARD P/E: 14.3xCapital deployment is eroding returns as CapEx scaled to $28.36B in FY 2025 while annual ROIC collapsed from 29.8% in FY 2022 to 11.3% in FY 2025 and 7.5% in Q1 2026, accompanied by operating margins dropping to 8.2% from 18.8% over the same multi-year horizon.
ROIC: 7.5% (Q1 2026) | OPERATING MARGIN: 8.2% | FY25 CAPEX: $28.36BTrading at 29.2x Trailing P/E and 13.7x EV/EBITDA, the equity offers a compressed 2.54% FCF yield, while balance sheet cash deteriorated from $31.54B in FY 2023 to $8.44B in Q1 2026 alongside debt scaling to $47.66B.
TRAILING P/E: 29.2x | EV/EBITDA: 13.7x | FCF YIELD: 2.54%RSI-14 stands overbought at 73.0 while the stock trades $42.25 above its Max Pain strike of $145.00, compounded by a weak Piotroski F-Score of 4/9 reflecting sequential operational margin and liquidity deterioration.
RSI-14: 73.0 | MAX PAIN: $145.00 | PIOTROSKI F-SCORE: 4/9| FILER | SIDE | $ VALUE |
|---|---|---|
| Rep. Mark Green | BUY | $540.6K |
| Berkshire Hathaway (Warren Buffett) | BUY | $337.2M |
| The Vanguard Group, Inc. | BUY | $245.0M |
| BlackRock, Inc. | BUY | $190.0M |
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| $180 (2026-11-06) | PUT | $484.7K |
| $190 (2026-11-06) | CALL | $751.7K |
| $188 (2026-11-13) | PUT | $1.3M |
| $188 (2026-11-06) | CALL | $468.9K |
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for XOM & activate live FRED threshold breach alerts.